Skip to main content
. 2021 Feb 24;51(5):693–699. doi: 10.1093/jjco/hyab013

Figure 1.

Figure 1.

Plasma concentration of (A) niraparib after a single dose (day 1 of cycle 1), (B) niraparib after multiple doses (day 21 of cycle 1), (C) M1 after a single dose (day 1 of cycle 1), and (D) M1 after multiple doses (day 21 of cycle 1). Data are mean (standard deviation).